Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-04

Clinical Trial Update: Evaluation of the Efficacy of Oral Tranexamic Acid and Glutathione-assisted Microneedling in Treatment of Melasma [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating the efficacy of oral tranexamic acid and glutathione-assisted microneedling for melasma; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glutathione (glutathione)
  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Assiut University | Conditions: Melasma | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING